Search results
Moderna says its RSV shot is 50% effective across a second season
Reuters via Yahoo News· 2 days agoIn their clinical trials, GSK's RSV vaccine Arexvy was 78% effective in preventing severe RSV over a...
Vaccine makers' stocks fall as CDC advisers shift RSV-shot recommendations
Morningstar· 2 days agoShares of vaccine makers Pfizer Inc., GSK PLC and Moderna Inc. dropped Wednesday as advisers to the Centers for Disease Control and Prevention shifted their ...
Moderna loses $5B in market value after new data on RSV vaccine - Boston Business Journal
The Business Journals· 1 day agoAn 18-month analysis showed that Moderna’s vaccine was just 50.3% effective at preventing lower...
New Covid Shots Recommended for Americans 6 Months and Older This Fall
New York Times· 12 hours agoAs the virus continues to mutate, the C.D.C. urged Americans to roll up their sleeves again for...
German vaccine panel endorses Astra-Sanofi's RSV shot for infants
Reuters via Yahoo News· 21 hours agoGermany's influential vaccine advisory panel said on Thursday all infants in the country should...
GSK shares slide after US health agency narrows scope of RSV shots
Reuters via AOL· 1 day agoBritain's GSK launched RSV vaccine Arexvy in the United States last summer after it and a rival shot...
What to Know About Bird Flu Vaccines
Time via Yahoo News· 1 day agoMore: A New Bird Flu Death Is Making Experts Uneasy Several academic institutions and pharmaceutical companies are working on an mRNA H5N1 vaccine. ...
Fluffy's Drugmaker Plummets On Unexpected Safety Warning
Investor's Business Daily· 13 hours agoThe company now expects it eczema drug Zenrelia to gain Food and Drug Administration approval in the third quarter and for its parasiticide, Ceredelio Quattro, to win approval in the fourth ...
US CDC narrows age recommendation for RSV shots in US
Reuters via Yahoo News· 2 days ago(Reuters) -The U.S. CDC on Wednesday narrowed its recommendation for use of respiratory syncytial...
Moderna says its RSV shot is 50% effective across a second season
Reuters· 2 days agoIn their clinical trials, GSK's RSV vaccine Arexvy was 78% effective in preventing severe RSV over a...
